[Drug Dispensing Remuneration Revision_Doubt Interpretation 6] Regarding Facility Standards for Electronic Dispensing Information Linkage System Maintenance Enhancement Fee – dgs-on

News Summary

The sixth installment of doubt interpretations regarding the 2026 drug dispensing remuneration revision has outlined the facility standards for the Electronic Dispensing Information Linkage System Maintenance Enhancement Fee. This enhancement fee evaluates the system that utilizes the online eligibility confirmation system, obtains patient consent, and shares information such as medication history with other medical institutions. Specific linkage methods, scope of information sharing, and consent acquisition processes are defined as facility standards.

Perspective from M&A Medical Editorial Department

This doubt interpretation specifies the facility standards for the “Electronic Dispensing Information Linkage System Maintenance Enhancement Fee” in the drug dispensing remuneration revision. This requires not only the introduction of a system but also the establishment of an information sharing system based on patient consent. For pharmacy managers, this suggests that alongside IT investment, building trust with patients and establishing information linkage processes can directly lead to increased revenue. Particularly for pharmacy managers considering succession or business transfer due to a lack of successor, meeting such enhancement fee requirements can be a crucial factor in increasing the pharmacy’s added value and favorably positioning it in the M&A market. From the perspective of strengthening regional healthcare collaboration, it will also serve as material to appeal future business continuity and development potential.

Points Highlighted by This News

• Facility standards for the Electronic Dispensing Information Linkage System Maintenance Enhancement Fee have been specified, potentially leading directly to increased pharmacy revenue.
• The establishment of an information sharing system based on patient consent, not just IT adoption, is required.
• For pharmacies lacking a successor, meeting the enhancement fee requirements can enhance their valuation in the M&A market.
• Strengthening regional healthcare collaboration can be used to appeal business continuity and development potential.

Practical Questions Arising from This News

• What specific system implementation and operational structures are necessary to meet the facility standards for this enhancement fee?
• What are effective methods for explaining and obtaining patient consent smoothly, and what are suitable consent form formats?
• How will the status of the information linkage system be evaluated during M&A due diligence?

If You Feel “Should I Consult?”

Are you considering confirming whether your pharmacy meets the facility standards for the Electronic Dispensing Information Linkage System Maintenance Enhancement Fee, or the specific steps needed to meet them? Furthermore, if you are seeking expert advice on how acquiring this enhancement fee will affect your pharmacy’s valuation in future business succession or M&A, please feel free to consult us. We will assist you in assessing the alignment between your current management strategy and your business succession plan.

M&A Medical (CentralMedience Co., Ltd.) is an M&A support institution certified by the Small and Medium Enterprise Agency, supporting the business succession of medical corporations, hospitals, and clinics on a complete success fee basis. We handle consultations with strict confidentiality. Free consultations are available here.